Progen

Developer of immunotherapies for immune diseases and cancer

placeSeoul, Seoul, South Korea calendar_todayFounded 2000 language progen.co.kr

Registered entities

Investor mix

1 investor on record; lead investors include Yuhan Corporation.

Investor typeCountShare
Other / undisclosed1100%
Coming soon